Skip to content

Clinical trials

Phase 3 Gastrointestinal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Diseases Phase: Phase 3 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20111
20121
20162
20171
20181
20202
20213
20223
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.3
Ellodi Pharmaceuticals, LP3
Celgene2
Pfizer2
Zealand Pharma2
Astra USA1
AstraZeneca1
Cook MyoSite1
Forest Laboratories1
Furiex Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Diseases24
Digestive System Diseases14
Intestinal Diseases13
Gastroenteritis10
Colonic Diseases9
Rectal Diseases7
Esophageal Diseases6
Inflammatory Bowel Diseases6
Pathologic Processes6
Colitis, Ulcerative5

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.